← Back to Search

Behavioral Intervention

ENGAGE Intervention for Post-COVID Support in People With Disabilities

N/A

Waitlist Available

Led By Joy Hammel, PhD

Research Sponsored by University of Illinois at Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 8 weeks

Awards & highlights

Study Summary

This trial will examine how a community-based intervention helps people with disabilities during the pandemic, like social participation and satisfaction. Results will help inform a future trial.

Who is the study for?

This trial is for English-speaking individuals with disabilities who feel socially isolated, especially due to the pandemic. They must live in a community setting and be able to express their interest in participating verbally. People with severe communication impairments that limit this ability cannot join.Check my eligibility

What is being tested?

The study is testing ENGAGE, an intervention aimed at reducing social isolation among people with disabilities post-COVID. It's a preliminary study focusing on how well the program works in terms of attracting and keeping participants, as well as its impact on improving social involvement.See study design

What are the potential side effects?

Since ENGAGE is a social participation intervention rather than a medical treatment, it does not have traditional side effects like drugs do. However, participants may experience emotional or psychological responses to increased social interaction.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility

Satisfaction

Secondary outcome measures

Social Participation

Trial Design

1Treatment groups

Experimental Treatment

Group I: ENGAGEExperimental Treatment1 Intervention

ENGAGE uses social learning, guided problem-solving and applied skill training to promote social participation among people with disabilities within the context of the COVID-19 pandemic. This is a group intervention using a self-management framework.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

ENGAGE

2013

Completed Phase 2

~180

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Center for Advancing Translational Sciences (NCATS)NIH

322 Previous Clinical Trials

401,742 Total Patients Enrolled

University of Illinois at ChicagoLead Sponsor

609 Previous Clinical Trials

1,559,288 Total Patients Enrolled

Joy Hammel, PhDPrincipal InvestigatorUniversity of Illinois Chicago

1 Previous Clinical Trials

38 Total Patients Enrolled

Media Library

ENGAGE (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05792852 — N/A

Multiple Disabilities Research Study Groups: ENGAGE

Multiple Disabilities Clinical Trial 2023: ENGAGE Highlights & Side Effects. Trial Name: NCT05792852 — N/A

ENGAGE (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05792852 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do you have any vacancies for those interested in participating in this trial?

"It appears this trial is no longer enrolling patients, as the last update to clinicaltrials.gov was on March 27th of 2023. There are fortunately 4 other trials that are currently in need of participants at this time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Improving the Health and Social Participation of People With Disabilities From Underrepresented Groups Post COVID

Joy M Hammel 2023. "Improving the Health and Social Participation of People With Disabilities From Underrepresented Groups Post COVID". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05792852.